*Mycobacterium leprae*, the causative agent of leprosy, cannot be grown axenically. The preferred system for cultivation of highly viable *M. leprae* for research purposes is the athymic nude mouse footpad (FP) model consisting of injecting *M. leprae* into each of the hind FP of nude mice and purification of bacteria from FP tissues 5--7 months postinfection ([@bb0025]). The current protocol for purification of highly viable bacteria from this model requires extensive mincing of the tissue with scissors, the production of a tissue homogenate using a hand-held glass tissue grinder and differential centrifugation ([@bb0025]). Although this technique produces highly purified, viable *M. leprae*, it is tedious, physically demanding and time consuming, especially when *M. leprae* is being harvested from large numbers of infected mice within a short time frame. Therefore, the objective of this study was to develop a simpler, semi-automated protocol for purification of *M. leprae* from infected FP tissues using a gentleMACS™ Dissociator.

These studies were performed under a scientific protocol reviewed and approved by the National Hansen\'s Disease Programs Institutional Animal Care and Use Committee (Assurance \#A3032-01), and were conducted in accordance with all state and federal laws in adherence with PHS policy and as outlined in the Guide for the Care and Use of Laboratory Animals, Eighth Edition. Athymic *nu/nu* mice (Harlan Sprague--Dawley, Inc., Indianapolis, IN) were euthanized 5--7 months postinfection with *M. leprae* Thai-53. The hind legs were removed and decontaminated with Betadine for 20 min and rinsed in 4 washes of 70% ethanol. The skin was removed and the FP tissue was excised and weighed. For the purification of *M. leprae* from FP tissues using the gentleMACS protocol both feet were dissected into small pieces using a disposable scalpel. Tissue from a single mouse was added to a gentleMACS™ M tube (Miltenyi BioTec, [www.gentleMACS.com](http://www.gentleMACS.com){#ir0015}) containing 10 ml RPMI-1640 (Life Technologies, Grand Island, NY) and 50 μg/ml ampicillin (Sigma-Aldrich) (RPMI/Amp). Tissues from 6 mice were simultaneously dissociated in a single run using the Protein 1 setting of a gentleMACS™ Octo Dissociator (Miltenyi BioTec) for 53 s and cooled on ice for 2 min, and the process was repeated twice. Each homogenate was transferred to a sterile 15 ml conical centrifuge tube and tissue debris was removed by centrifugation at 100 ×*g*, 2 min at 25 °C. Bacteria were pelleted at 10,000 ×*g*, 30 min at 4 °C, resuspended in RPMI/Amp + 10% FBS (Hyclone Laboratories, Logan, UT) and incubated at 37 °C for 1 h to remove potential microbial contaminants. Bacterial pellets were treated with 0.1 NaOH for 8 min to remove residual tissue debris and washed  3× in RPMI 1640 + 10% FBS Amp. For comparison, *M. leprae* were also purified from FP tissues using the standard hand-held homogenization technique ([@bb0025]). Briefly, FP tissue from a single mouse was minced to a fine consistency for 3 min using a sterile pair of curved scissors. Tissue was transferred to a sterile 40 ml glass Wheaton Tenbroeck Tissue Grinder (Cat \#08-414-13D, Fisher Scientific) and gently homogenized by hand on ice in 10 ml RPMI/Amp + 10% FBS for 5 min or until suspension looked milky. Bacteria were clarified, pelleted, incubated at 37 °C with Amp, and treated with NaOH as described above. Data from 6 mice per protocol were analyzed using two-tailed paired *t* test and compared by group using GraphPad software ([www.graphpad.com/quickcalcs/ttest1.cfm](http://www.graphpad.com/quickcalcs/ttest1.cfm){#ir0020}) and considered significant at *p* value ≤ 0.05.

The hand-held homogenization protocol produced \~ 2-fold more *M. leprae* than the gentleMACS protocol according to acid-fast stain counts (*p*-value = 0.03) ([@bb0020]) ([Table 1](#t0005){ref-type="table"}). No significant differences were observed in the viability of *M. leprae* preparation using the LIVE/DEAD BacLight Bacterial Viability Kit (Molecular Probes) ([@bb0015]) and preparations exhibited similar levels of metabolic activity as determined using Buddemeyer radiorespirometry ([@bb0005]). Scanning electron microscopy using an FEI Quanta 200 scanning electron microscope showed that both bacterial preparations were relatively free of mouse cellular debris ([Fig. 1](#f0005){ref-type="fig"}).

A novel semi-automated procedure for the purification of *M. leprae* from infected tissues has been described. The gentleMACS protocol uses disposable scalpels and tissue dissociation tubes (M-tubes), eliminating the need for decontamination, cleaning and sterilizing of re-useable equipment such as scissors, forceps and glass homogenizers required for the hand-held homogenization protocol. Therefore, the preparation and clean-up time for a harvest is greatly minimized. The gentleMACS protocol FP homogenization step is automated while the hand-held method is very tedious and physically demanding, requiring 3 min of mincing with curved scissors prior to at least 5 min of gentle homogenization with a hand-held glass tissue grinder for each mouse. In addition, FP tissue from 8 mice can be homogenized in the gentleMACS Octo Dissociator in the same amount of time it takes to process the tissue from a single mouse with the hand-held homogenization method. Bacterial yields are \~ 2-fold lower with the gentleMACS protocol however viability and metabolic activity of *M. leprae* are comparable with both methods. We anticipate that this procedure will replace the current hand-held tissue homogenization protocol for purification of *M. leprae* from infected tissues for most research purposes. This will be especially beneficial when studies require large numbers of mice to be harvested in a short period of time, such as is common for vaccine or drug studies which can require 50--60 mice.
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![Scanning electron micrographs (10,000 × magnification) of purified *M. leprae* preparations from: A) hand-held homogenization protocol and B) gentleMACS protocol.](gr1){#f0005}

###### 

Comparison of gentleMACS vs hand-held homogenization protocols for purification of *M. leprae* from mouse footpad (FP) tissue.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Protocol                      Bacterial yield[a](#tf0005){ref-type="table-fn"}\   \% viability[b](#tf0010){ref-type="table-fn"}   Radiorespirometry[c](#tf0015){ref-type="table-fn"}\                 
                                AFB/mg FP tissue                                                                                    CPM/10^6^*M. leprae*                                                
  ----------------------------- --------------------------------------------------- ----------------------------------------------- ----------------------------------------------------- ------ ------ ------
  gentleMACS Octo Dissociator   1.5 × 10^7^                                         0.59 × 10^7^[d](#tf0020){ref-type="table-fn"}   82.5%                                                 4.6%   3435   2056

  Hand-held homogenization      3.4 × 10^7^                                         0.86 × 10^7^                                    84.5%                                                 6.7%   4203   2592
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Bacterial yield = number of acid fast-stained bacterial counts/mg of FP (n = 6 mice/12 FP).

\% viability = LIVE/DEAD BacLight Bacterial Viability Kit (Molecular Probes).

Radiorespirometry = Buddemeyer radiorespirometry (CPM)/10^6^*M. leprae* (7 d readings).

Significance at *p* = 0.03 using two-tailed paired *t*-test.
